ABVC BioPharma, Inc.
ABVC
$2.41
-$0.12-4.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.12M | -3.26M | -1.95M | -3.94M | -4.55M |
| Total Depreciation and Amortization | 470.00K | 480.40K | 513.90K | 502.50K | 682.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.35M | 1.46M | 253.00K | 2.16M | 2.91M |
| Change in Net Operating Assets | -764.00K | -542.20K | -1.90K | -321.20K | -577.90K |
| Cash from Operations | -2.06M | -1.87M | -1.18M | -1.60M | -1.54M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.94M | -621.00K | -456.80K | -456.80K | -302.60K |
| Cash from Investing | -1.94M | -621.00K | -456.80K | -456.80K | -302.60K |
| Total Debt Issued | 848.60K | 25.10K | 905.20K | 1.22M | 637.80K |
| Total Debt Repaid | -616.10K | -459.50K | -385.40K | -356.10K | -365.60K |
| Issuance of Common Stock | 3.84M | 3.30M | 1.39M | 978.50K | 902.20K |
| Repurchase of Common Stock | -7.30K | -7.30K | -7.30K | -7.30K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -171.70K | 394.10K | 508.90K |
| Cash from Financing | 4.07M | 2.86M | 1.73M | 2.23M | 1.68M |
| Foreign Exchange rate Adjustments | 14.10K | -34.30K | 10.90K | -22.00K | -194.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.10K | 333.60K | 100.60K | 147.00K | -351.10K |